Corporate Filings
SEC Filing: Medline Inc. (MDLN) Reports An executive or director departure
Medline Inc. (MDLN) disclosed an executive or director departure in a Form 8-K filed with the SEC on 2026-10-15.
Max I. · October 16, 2026
A Form 8-K filed by Medline Inc. (MDLN) with the SEC on 2026-10-15 discloses an executive or director departure.
Public companies are required to file a Form 8-K with the SEC within four business days of a material corporate event, covering matters ranging from leadership changes to major agreements and financial results.
Investors can review the full filing directly through the SEC's EDGAR database for additional detail beyond what is summarized here.
More in Corporate Filings
Corporate Filings
UNITIL CORP (UTL) Files 8-K Regarding Entry into a material definitive agreement
Max I. · Oct 27, 2026
Corporate Filings
SEC Filing: WEST PHARMACEUTICAL SERVICES INC (WST) Reports Entry into a material definitive agreement
Max I. · Oct 27, 2026
Corporate Filings
SEC Filing: Senti Biosciences Holdings, Inc. (SNTI) Reports Entry into a material definitive agreement
Max I. · Oct 27, 2026
Corporate Filings
HyOrc Corp (HYOR) Discloses Entry into a material definitive agreement in New SEC Filing
Max I. · Oct 26, 2026
